-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Immune checkpoint inhibitors (ICI) have become a breakthrough treatment for certain cancer patients including brain metastases (BM).
immunity
This study aims to conduct a systematic literature review and meta-analysis of the relationship between steroid therapy and overall survival (OS) in BM patients treated with ICI.
This study aims to conduct a systematic literature review and meta-analysis of the relationship between steroid therapy and overall survival (OS) in BM patients treated with ICI.
1145 studies were screened and 15 observational studies were included.
Forest plot of overall survival (OS) hazard ratio (HR) for patients with brain metastases in the steroid and non-steroid groups
Forest plot of overall survival (OS) hazard ratio (HR) for patients with brain metastases in the steroid and non-steroid groupsThe median OS of patients in the steroid group was 2.
The median OS of patients in the steroid group was 2.
In BM patients receiving ICI treatment, hormone therapy was associated with a significant deterioration in OS and PFS.
Original source:
Jessurun Charissa AC, Hulsbergen Alexander FC, de Wit Anouk E et al.
org/10.
1093/neuonc/noab046">The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis in this message